Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages. (2020)

First Author: Heinrich ML
Attributed to:  One Health and accelerating Vaccines for Ebola and Lassa (OVEL) funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-020-72539-w

PubMed Identifier: 32994446

Publication URI: http://europepmc.org/abstract/MED/32994446

Type: Journal Article/Review

Volume: 10

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322